Cessation of platelet-mediated cyclic canine coronary occlusion after thrombolysis by combining nitric oxide inhalation with phosphodiesterase-5 inhibition

Journal of the American College of Cardiology

Volumn 37, Issue 7, 2001, Pages 1981-1988

  Schmidt, Ulrich ^a   Han, Richard O ^a   DiSalvo, Thomas G ^a   Guerrero, J Luis ^a   Gold, Herman K ^a   Zapol, Warren M ^a   Bloch, Kenneth D ^a   Semigran, Marc J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR; ZAPRINAST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING TIME; BLOOD CLOT LYSIS; CONTROLLED STUDY; DOG; DRUG EFFECT; ENZYME INHIBITION; HEART INFARCTION; NONHUMAN; PRIORITY JOURNAL; REVASCULARIZATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; VASCULAR SMOOTH MUSCLE;

ADMINISTRATION, INHALATION; ANIMALS; BLOOD PLATELETS; CORONARY THROMBOSIS; DIPYRIDAMOLE; DOGS; DRUG THERAPY, COMBINATION; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITORS; PURINONES; THROMBOLYTIC THERAPY;

EID: 0035369121     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01270-0     Document Type: Article

References (30)

1. Acute coronary syndromes: Unstable angina and non-Q-wave myocardial infarction
2. Platelets and thrombolytic therapy
3. The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
4. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
5. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
6. Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: A randomized trial
7. A perspective on the potential problems with aspirin as an antithrombotic agent: A comparison of studies in an animal model with clinical trials
8. Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A
9. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro
10. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes
11. Inhibition of human platelet aggregation by S-nitrosothiols: Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation
12. Sodium nitroprusside, an endothelium-derived relaxing factor congener, increases platelet cyclic GMP levels and inhibits epinephrine-exacerbated in vivo platelet thrombus formation in stenosed canine coronary arteries
13. Dipyridamole potentiates the anti-aggregating and vasodilator activity of nitric oxide
14. Anti-platelet action of nitric oxide and selective phosphodiesterase inhibitors
15. In vitro and in vivo interactions of nitrovasodilators and zaprinast, a cGMP-selective phosphodiesterase inhibitor
16. Interaction of Viagra with the NO donors molsidomine and RE2047 with regard to antithrombotic and blood pressure lowering activities
17. Inhaled nitric oxide: Basic biology and clinical applications
18. Prolonged bleeding time during nitric oxide inhalation in the rabbit
19. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient
20. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways
21. Inhaled nitric oxide increases coronary artery patency after thrombolysis
22. Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparation
23. Nitric oxide inhalation inhibits platelet aggregation and platelet-mediated pulmonary thrombosis in rats
24. The effect of inhaled nitric oxide therapy on bleeding time and platelet aggregation in neonates
25. Inhaled nitric oxide and inhibition of platelet aggregation in critically ill neonates
26. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome
27. Dipyridamole
28. 2 synthesis in human blood platelets
29. Cell-free and erythrocytic S-nitrosohemoglobin inhibits human platelet aggregation
30. Reaction of dipyridamole with the hydroxyl radical